Urology Cancer Center — Omaha, Nebraska

Public research footprint of Urology Cancer Center, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

mCRPC (Metastatic Castration-resistant Prostate Cancer) · Prostate Cancer · Prostatic Neoplasms · Recurrent Neck Squamous Cell Carcinoma of Unknown Primary

Recently updated registry entries

NCT04887870 — Study of Sitravatinib With or Without Other Anticancer Therapies Receiving Clinical… (Completed)
NCT01272037 — Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in… (Active Not Recruiting)
NCT06801236 — Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Urology Cancer Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.